Takuya Fujita

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Pharmaceutics

Physiological reports

Metabolites

Pharmacology research & perspectives

Ritsumeikan Daigaku - Biwako Kusatsu Campus

Kyoto University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ritsumeikan Daigaku - Biwako Kusatsu Campus Apr 01 2008

Japan

Professor :: College of Pharmaceutical Sciences

Ritsumeikan Daigaku - Biwako Kusatsu Campus Apr 01 2007 - Mar 31 2008

Japan

Professor :: College of Information Science and Engineering

Kyoto Pharmaceutical University Apr 01 2000 - Mar 31 2007

Japan

Associate Professor :: Biochemical Pharmacology

Kyoto Pharmaceutical University Apr 01 1998 - Mar 31 2000

Japan

Assistant Professor :: Biopharmaceutics

Kyoto Pharmaceutical University Mar 01 1992 - Mar 31 1998

Japan

Research Associate :: Biopharmaceutics

Education History

Kyoto University Apr 01 1988 - Mar 31 1990

Japan

MSC :: Graduate School of Pharmaceutical Sciences

Kyoto University Apr 01 1984 - Mar 31 1988

Japan

BSC :: Faculty of Pharmaceutical Sciences

Publications

Junya Takegaki, Kohei Sase, Yusuke Kono, Takuya Fujita, Satoshi Konishi, Satoshi Fujita
Intramuscular injection of mesenchymal stem cells augments basal muscle protein synthesis after bouts of resistance exercise in male mice. Physiological reports 12 (7) (2024)
Junya Takegaki, Kohei Sase, Yusuke Kono, Takuya Fujita, Satoshi Konishi, Satoshi Fujita
Intramuscular injection of mesenchymal stem cells augments basal muscle protein synthesis after bouts of resistance exercise in male mice. Physiological reports 12 (7) (2024)
Junya Takegaki, Kohei Sase, Yusuke Kono, Takuya Fujita, Satoshi Konishi, Satoshi Fujita
Intramuscular injection of mesenchymal stem cells augments basal muscle protein synthesis after bouts of resistance exercise in male mice. Physiological reports 12 (7) (2024)
Rodi Abdalkader, Romanas Chaleckis, Takuya Fujita
Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis. Metabolites 13 (6) (2023)
Rodi Abdalkader, Romanas Chaleckis, Takuya Fujita
Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis. Metabolites 13 (6) (2023)
Rodi Abdalkader, Romanas Chaleckis, Takuya Fujita
Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis. Metabolites 13 (6) (2023)
Masafumi Fukiage, Kyosuke Suzuki, Maki Matsuda, Yohei Nishida, Michinori Oikawa, Takuya Fujita, Kohsaku Kawakami
Inhibition of Liquid-Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil. Pharmaceutics 14 (12) (2022)
Ryosuke Negoro, Mitsuki Tasaka, Sayaka Deguchi, Kazuo Takayama, Takuya Fujita
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System. Cells 11 (10) (2022)
Masafumi Fukiage, Kyosuke Suzuki, Maki Matsuda, Yohei Nishida, Michinori Oikawa, Takuya Fujita, Kohsaku Kawakami
Inhibition of Liquid-Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil. Pharmaceutics 14 (12) (2022)
Masafumi Fukiage, Kyosuke Suzuki, Maki Matsuda, Yohei Nishida, Michinori Oikawa, Takuya Fujita, Kohsaku Kawakami
Inhibition of Liquid-Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil. Pharmaceutics 14 (12) (2022)
Masafumi Fukiage, Kyosuke Suzuki, Maki Matsuda, Yohei Nishida, Michinori Oikawa, Takuya Fujita, Kohsaku Kawakami
Inhibition of Liquid-Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil. Pharmaceutics 14 (12) (2022)
Rodi Abdalkader, Satoshi Konishi, Takuya Fujita
The Development of Biomimetic Aligned Skeletal Muscles in a Fully 3D Printed Microfluidic Device. Biomimetics (Basel, Switzerland) 7 (1) (2021)
Kyosuke Suzuki, Kohsaku Kawakami, Masafumi Fukiage, Michinori Oikawa, Yohei Nishida, Maki Matsuda, Takuya Fujita
Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions. Pharmaceutics 13 (2) (2021)
Yusuke Kono, Iichiro Kawahara, Kohei Shinozaki, Ikuo Nomura, Honoka Marutani, Akira Yamamoto, Takuya Fujita
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs. Pharmaceutics 13 (3) (2021)
Naoya Matsumura, Asami Ono, Yoshiyuki Akiyama, Takuya Fujita, Kiyohiko Sugano
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs. Pharmaceutics 12 (9) (2020)
Iichiro Kawahara, Satoyo Nishikawa, Akira Yamamoto, Yusuke Kono, Takuya Fujita
Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice. Pharmacology research & perspectives 8 (1) (2020)

Takuya Fujita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takuya Fujita